• Format

    Online
    Webinar

  • Date and Time

    January 13, 2026

  • Time

    13:00 CET

  • Level

    All

  • Price

    Free

Regulating Medical Devices in Switzerland

Switzerland’s medical-device rules have changed notably since the EU–Swiss MRA expired in 2021. These changes introduced new obligations for manufacturers, importers and foreign suppliers.
In this webinar, you’ll learn what has changed, how it affects market access, and what companies must do to remain compliant. We’ll walk through today’s regulatory landscape in simple terms — including Switzerland’s “third-country” status, the requirement for CH-REPs, the introduction of swissdamed, and the future option of bringing FDA-authorised devices to Switzerland.
This webinar is ideal for manufacturers, importers, distributors, regulatory specialists, and anyone involved in placing medical devices on the Swiss market.
Meet the instructor

Daniel Delfosse

Daniel Delfosse retired at the end of 2025 as Vice Director of Swiss Medtech, the industry association representing and promoting the interests of the Swiss medical technology industry. In this role as Head of Regulation & Innovation, he monitored legislation and ensured that the framework conditions remained competitive – with the goal of maintaining Switzerland’s position as a leading hub for the medtech industry. His mantra is "innovation despite regulation".
Daniel holds a degree in materials engineering from ETH Zurich and earned his doctorate at EPF Lausanne. Following a research stay at the University of British Columbia in Vancouver, he transitioned into the medtech industry. For nearly two decades, he led R&D at a Swiss orthopaedics company, working at the intersection of regulation and innovation. He is now semi-retired and has opened his own Delfosse Medtech Consulting GmbH.

Write your awesome label here.